Indometacin, troxerutin (Troximetacin) gel for local and external use – [40 g tube]

A combination drug for topical use, which consists of indomethacin and troxerutin.

Indomethacin has a pronounced anti-inflammatory, analgesic and anti-edema effect, resulting in pain relief, reduction of edema and reduction of recovery time of the affected tissues. The main mechanism of action is related to inhibition of prostaglandin synthesis by reversible blockade of cyclooxygenase 1 and 2.

Troxerutin (trihydroxyethylrutinoside) is a bioflavonoid. It has an angioprotective effect. Reduces capillary permeability and venotonic effect. It blocks the venodilator effect of histamine, bradykinin and acetylcholine. It has anti-inflammatory effect on the periovenous tissue, reduces capillary fragility and has some anti-aggregant effect. It reduces swelling, improves trophism in various pathological changes associated with venous insufficiency.

Troksimetacin gel when applied to the skin suppresses the inflammatory edematous reaction, reduces pain and fever in the inflammation foci on the surface and in the depths, reaching the blood vessels located there. It has a pronounced venotonic, capillary-protective effect.

For symptomatic treatment:

– In the complex treatment of chronic venous insufficiency of the lower extremities (varicose veins) – to relieve swelling, feeling of heaviness and pain in the legs;

– Surface thrombophlebitis, phlebitis, postphlebitis;

– Rheumatic soft tissue disorders: tendovaginitis, bursitis, fibrositis, periarthritis;

– Postoperative swelling, contusions, sprains, sprains.

Contraindications .

– Hypersensitivity to the components of the drug;

– Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs);

– III trimester of pregnancy and breast-feeding period;

– Children under 14 years of age (because of the lack of clinical experience of application);

– Skin integrity disorders.

Caution:

Simultaneous use of the drug with other NSAIDs, bronchial asthma, allergic runny nose, nasal polyps.

Pregnancy and lactation:

There is no clinical experience proving the safety of the drug when used during pregnancy and lactation. The drug administration is possible only in case when the expected benefits to the mother exceed the potential risk to the fetus or child.